| __timestamp | Arrowhead Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 23138050 | 55430000 |
| Thursday, January 1, 2015 | 57410147 | 65510000 |
| Friday, January 1, 2016 | 41454452 | 71160000 |
| Sunday, January 1, 2017 | 31690298 | 70644000 |
| Monday, January 1, 2018 | 52968505 | 70418000 |
| Tuesday, January 1, 2019 | 81048686 | 63238000 |
| Wednesday, January 1, 2020 | 128874979 | 59777000 |
| Friday, January 1, 2021 | 206342000 | 60152000 |
| Saturday, January 1, 2022 | 297307000 | 54540000 |
| Sunday, January 1, 2023 | 353188000 | 52243000 |
| Monday, January 1, 2024 | 505870000 | 64536000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Arrowhead Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have shown contrasting trends in their R&D investments. From 2014 to 2024, Arrowhead Pharmaceuticals has increased its R&D spending by an impressive 2,100%, reflecting its aggressive pursuit of new drug development. In contrast, Taro Pharmaceutical's R&D expenses have remained relatively stable, with only a slight increase of around 16% over the same period. This divergence highlights Arrowhead's strategic focus on expanding its research capabilities, while Taro maintains a steady approach. As the pharmaceutical landscape evolves, these spending patterns may influence each company's future market position and innovation potential.
Johnson & Johnson vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Teva Pharmaceutical Industries Limited vs Taro Pharmaceutical Industries Ltd.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Incyte Corporation vs Taro Pharmaceutical Industries Ltd.
Summit Therapeutics Inc. vs Arrowhead Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Exelixis, Inc. and Arrowhead Pharmaceuticals, Inc.
R&D Spending Showdown: Exelixis, Inc. vs Taro Pharmaceutical Industries Ltd.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Arrowhead Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Pharming Group N.V. vs Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Grifols, S.A. vs Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Iovance Biotherapeutics, Inc. vs Taro Pharmaceutical Industries Ltd.
R&D Insights: How MannKind Corporation and Taro Pharmaceutical Industries Ltd. Allocate Funds